First elected: 7th May 2015
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
These initiatives were driven by Peter Dowd, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Peter Dowd has not been granted any Urgent Questions
Peter Dowd has not been granted any Adjournment Debates
A Bill to amend the Working Time Regulations 1998 to reduce the maximum working week from 48 hours per week to 32 hours per week and to provide for overtime pay; and for connected purposes.
Microplastic filters (washing machines) Bill 2024-26
Sponsor - Alberto Costa (Con)
Fireworks (Noise Limits) Bill 2023-24
Sponsor - Judith Cummins (Lab)
Multi-storey car parks (safety) Bill 2022-23
Sponsor - Maria Eagle (Lab)
Planning and Local Representation Bill 2021-22
Sponsor - Rachel Hopkins (Lab)
Remote Participation in House of Commons Proceedings (Motion) Bill 2019-21
Sponsor - Dawn Butler (Lab)
Public Advocate (No. 2) Bill 2019-21
Sponsor - Maria Eagle (Lab)
Remote Participation in House of Commons Proceedings Bill 2019-21
Sponsor - Dawn Butler (Lab)
The extra costs disability benefits, Attendance Allowance, Disability Living Allowance and Personal Independence Payment (PIP), provide a contribution towards the extra costs that may arise from a long-term disability or health condition. These benefits are assessed on the basis of needs arising and not on the condition itself, so are available to those with bipolar disorder and other mood disorders when they meet the qualifying criteria.
The extra costs benefits are non-contributory, non-means-tested and can be worth over £9,500 a year, tax free. Individuals can choose how to use their benefit, in the light of their individual needs and preferences. They were not subject to the benefits freeze, were most recently uprated by 6.7 per cent from 8 April 2024 and, subject to Parliamentary approval, are due to be uprated by 1.7 per cent from April this year.
The benefits can also be paid in addition to any other financial or practical support someone may be entitled to such as Universal Credit, Employment and Support Allowance, NHS services, free prescriptions or help with travel costs to appointments. They can also attract additional support such as premiums and additional amounts paid within the income-related benefits, access to Carer’s Allowance, the Motability scheme and the Blue Badge scheme.
The Work Capability Assessment is not working and needs to be reformed or replaced alongside a proper plan to help disabled people into work, which will help them, businesses and the economy.
We know that change is desperately needed but equally these sorts of changes should not be made in haste.
So, alongside our Get Britain Working White Paper, we want to engage with disabled people, and others with expertise and experience on these issues, to consider how to address these challenges and build a better system.
We will reconsult on the proposed WCA changes as part of our Green Paper before the Spring 2025 forecast that will bring forward wider proposals to reform the health and disability benefits system. The reforms will be subject to full consultation.
Backed by £240m investment, the Get Britain Working White Paper launched on 26 November will drive forward approaches to tackling economic inactivity and work toward the long-term ambition of an 80% employment rate.
Employers play a key role in increasing employment opportunities and supporting disabled people and people with health conditions, to thrive as part of the workforce. Our support to employers includes increasing access to Occupational Health, a digital information service for employers and the Disability Confident scheme.
Appropriate work is generally good for health and wellbeing, so we want everyone to get work and get on in work, whoever they are and wherever they live.
Disabled people and people with health conditions, including people with bipolar disorder, are a diverse group so access to the right work and health support, in the right place, at the right time, is key. We therefore have a range of specialist initiatives to support individuals to stay in work and get back into work, including those that join up employment and health systems.
Measures include support from Work Coaches and Disability Employment Advisers in Jobcentres and Access to Work grants, as well as joining up health and employment support around the individual through Employment Advisors in NHS Talking Therapies and Individual Placement and Support in Primary Care.
Ministers hold discussions with other ministerial colleagues regularly, on a range of issues.
The Get Britain Working White Paper confirms the Government’s commitment to continuing to expand the number of places on Individual Placement Support schemes to help thousands more people with severe mental illness, including bipolar disorder, to find and stay in employment.
The White Paper also confirms our commitment to expand NHS Talking Therapies. Over 90% of NHS Talking Therapies services in England provide access to Employment Advisers with an aspiration that, by March 2025, 99% will offer employment support as part of their service.
The standard of training for general practitioners and other health care practitioners is the responsibility of the independent statutory regulatory bodies. They set the outcome standards expected at undergraduate level and approve courses, and higher education institutions, which write and teach the curricula that enables their students to meet the regulators’ outcome standards.
Whilst not all curricula may necessarily highlight a specific condition, they all nevertheless emphasize the skills and approaches a health care practitioner must develop in order to ensure accurate and timely diagnoses and appropriate treatment plans for their patients, including those with bipolar disorder.
Once qualified, health care practitioners are responsible for ensuring their own clinical knowledge remains up to date, and for identifying learning needs as part of their continuing professional development. This should include taking account of new research and guidance, such as that produced by the National Institute for Health and Care Excellence, to ensure that they can continue to provide high-quality care to all patients.
The community mental health framework sets out a vision for transforming community mental health services. The vision is a whole person, whole population approach to community health services, with new integrated models between primary and secondary care that can deliver more flexible, personalised, and holistic care, including diagnosis, for more people with severe mental illnesses such as bi-polar disorder, rather than developing specialist pathways for specific conditions.
Since April 2021, all areas have received significant additional, ring-fenced funding to develop these new integrated primary and community mental health services, built around primary care networks, in line with the community mental health framework. Local health systems have made significant progress in rolling out these integrated models of care, including for people with a diagnosis of bi-polar disorder.
The standard of training for general practitioners and other health care practitioners is the responsibility of the independent statutory regulatory bodies. They set the outcome standards expected at undergraduate level and approve courses, and higher education institutions, which write and teach the curricula that enables their students to meet the regulators’ outcome standards.
Whilst not all curricula may necessarily highlight a specific condition, they all nevertheless emphasize the skills and approaches a health care practitioner must develop in order to ensure accurate and timely diagnoses and appropriate treatment plans for their patients, including those with bipolar disorder.
Once qualified, health care practitioners are responsible for ensuring their own clinical knowledge remains up to date, and for identifying learning needs as part of their continuing professional development. This should include taking account of new research and guidance, such as that produced by the National Institute for Health and Care Excellence, to ensure that they can continue to provide high-quality care to all patients.
The community mental health framework sets out a vision for transforming community mental health services. The vision is a whole person, whole population approach to community health services, with new integrated models between primary and secondary care that can deliver more flexible, personalised, and holistic care, including diagnosis, for more people with severe mental illnesses such as bi-polar disorder, rather than developing specialist pathways for specific conditions.
Since April 2021, all areas have received significant additional, ring-fenced funding to develop these new integrated primary and community mental health services, built around primary care networks, in line with the community mental health framework. Local health systems have made significant progress in rolling out these integrated models of care, including for people with a diagnosis of bi-polar disorder.
The standard of training for general practitioners and other health care practitioners is the responsibility of the independent statutory regulatory bodies. They set the outcome standards expected at undergraduate level and approve courses, and higher education institutions, which write and teach the curricula that enables their students to meet the regulators’ outcome standards.
Whilst not all curricula may necessarily highlight a specific condition, they all nevertheless emphasize the skills and approaches a health care practitioner must develop in order to ensure accurate and timely diagnoses and appropriate treatment plans for their patients, including those with bipolar disorder.
Once qualified, health care practitioners are responsible for ensuring their own clinical knowledge remains up to date, and for identifying learning needs as part of their continuing professional development. This should include taking account of new research and guidance, such as that produced by the National Institute for Health and Care Excellence, to ensure that they can continue to provide high-quality care to all patients.
The community mental health framework sets out a vision for transforming community mental health services. The vision is a whole person, whole population approach to community health services, with new integrated models between primary and secondary care that can deliver more flexible, personalised, and holistic care, including diagnosis, for more people with severe mental illnesses such as bi-polar disorder, rather than developing specialist pathways for specific conditions.
Since April 2021, all areas have received significant additional, ring-fenced funding to develop these new integrated primary and community mental health services, built around primary care networks, in line with the community mental health framework. Local health systems have made significant progress in rolling out these integrated models of care, including for people with a diagnosis of bi-polar disorder.
The Committee on Medical Aspects of Radiation in the Environment (COMARE) published a report on the health effects and risks arising from sunbeds in 2009. This report included a chapter on sunbed use in the United Kingdom, and informed the 2010 Sunbeds (Regulation) Act.
In November 2024, the Department commissioned COMARE to consider the available evidence relating to the use of sunbeds in the UK, and to determine if a new review is required. This work is ongoing, and its conclusions will be made publicly available when completed.
The Department continues to advise patients to follow National Health Service guidance on reducing the risk of skin cancer. This advice is available publicly on the National Health Service website, at the following link:
https://www.nhs.uk/conditions/melanoma-skin-cancer/
The Department is not taking any additional steps, currently or within the last three years, to specifically fund skin cancer awareness campaigns.
NHS England run Help Us Help You campaigns to increase knowledge of cancer symptoms and address the barriers to acting on them, to encourage people to come forward as soon as possible to see their general practitioner. The campaigns focus on a range of symptoms as well as encouraging body awareness to help people spot symptoms across a wide range of cancers at an earlier point.
The UK Rare Diseases Framework sets a high-level strategy to focus action across the healthcare system to address the four priorities of: helping patients get a final diagnosis faster; increasing awareness of rare diseases among healthcare professionals; better coordination of care; and improving access to specialist care, treatments, and drugs. Integrated care boards (ICBs) are responsible for commissioning some specialised healthcare services, which help treat patients with rare diseases, whereas others are commissioned centrally by NHS England. For those specialised services commissioned by ICBs, the ICBs must commission the services in line with service specifications and standards published by NHS England. NHS England remains accountable for the effective arrangement of those specialised services.
A rare disease is defined as a disease or condition which affects fewer than one in 2,000 people within the general population. While they are individually rare, they are collectively common, and one in 17 people will be affected by a rare disease at some point in their lives.
Improving the lives of people living with rare conditions continues to be a health priority. The UK Rare Diseases Framework sets out four priorities, collaboratively developed with the rare disease community, which are: helping patients get a final diagnosis faster; increasing awareness of rare diseases among healthcare professionals; better coordination of care; and improving access to specialist care, treatments, and drugs. We remain committed to delivering under the framework and will publish an annual England Action Plan in 2025, which will report on progress.
The annual England Action Plan sets out specific, measurable actions for the next year under the framework's four priority areas. To ensure delivery and accountability, each action lists an owner, the desired outcomes, and how we will measure and report on progress. We have also committed to commissioning a portfolio level evaluation of England’s Rare Diseases Action Plans to measure progress for people living with rare conditions. This evaluation is now underway, and we look forward to updating on next steps in 2025.
Improving the lives of people living with rare and ultra-rare conditions, such as rare blood disorders, continues to be a health priority. We remain committed to the UK Rare Diseases Framework, which highlights four priorities to improve the lives of people with rare diseases, including better coordination of care, and improved access to specialist care, treatment, and drugs.
We’re working hard to provide the best possible care to those living with rare blood disorders, such as sickle cell disease and thalassaemia. NHS England’s priorities for the improvement of care for rare blood disorders includes an established programme of work to improve clinical pathways and care for people with sickle cell disease, which has recently been expanded to include thalassaemia. We are also boosting Ro subtype blood donation numbers and delivering world-leading treatments, such as the new blood matching genetic test which will reduce the risk of side effects and offer more personalised care.
NHS England commissions services for patients with Thrombotic Thrombocytopenia Purpura across 11 hospitals. This is an aggressive blood clotting disease which is difficult to diagnose and has a high mortality rate if left untreated. In the acute phase of the disease patients need rapid access to specialist care. This is a lifelong condition, and patients receive ongoing monitoring by the multidisciplinary team, shared care with local hospitals, and access to specialist drugs.
The National Health Service is reviewing and updating the service specification for haemophilia care through the Blood Disorders Clinical Reference Group, alongside a new quality dashboard that will enable commissioners to monitor the quality of the services in their areas, benchmarked against other services across the country.
The UK Rare Diseases Framework sets out four priorities to improve the lives of people living with rare diseases, such as Paroxysmal Nocturnal Haemoglobinuria (PNH). This includes the priority of improving co-ordination of care.
NHS England commissions services for patients with PNH from two centres, the Leeds Teaching Hospitals NHS Trust and the King's College Hospital NHS Foundation Trust. These two services work collaboratively to provide specialist care and care coordination to patients with PNH in England. This involves specialist diagnosis, multidisciplinary team care, shared care with local hospitals, and access to specialist drugs. The centres also provide outreach clinics. The service is recognised as an exemplar and has reduced mortality and improved outcomes for patients.
We remain committed to the UK Rare Diseases Framework, which highlights better coordination of care as a priority to improve the lives of people with rare diseases.
Under England’s Rare Diseases Action Plans, we have committed to a range of measures to improve coordination of care. Last year, the National Institute for Health and Care Excellence published an updated quality standard on transition from paediatric to adult care, to support better co-ordination of care. NHS England continues to review and approve applications for new rare disease collaborative networks (RDCNs) across a range of specialties and disease groups. The RDCNs are an important part of NHS England’s provision to improve care and support patients with rare diseases. They are made up of groups of providers who have an interest in developing an understanding of a particular rare disease, and who are committed to working together to progress research, increase knowledge, and improve patient experience.
NHS England committed to include the definition of coordination of care in all new and revised services specifications for patients with rare diseases, and to ensure the priorities of the UK Rare Diseases Framework are embedded across highly specialised services. All highly specialised centres are required to work collaboratively with other providers in the service and to have shared care arrangements in place with local hospitals, as required.
NHS England is implementing networked models of care for patients with rare diseases, ensuring that specialist expertise is always available whilst allowing patients to be treated and cared for as close to home as possible. In addition, NHS England has committed to measuring the geographic spread of patients accessing highly specialised services to ensure that all patients have access to the services, and are not disadvantaged. A toolkit for virtual consultations was developed in 2023, and made available to all trust chief executives and highly specialised services clinical leads, to help people with complex, multi-system rare diseases access multiple specialists without needing to travel.